The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Wynzora
Calcipotriene and Betamethasone dipropionate · CALCIPOTRIENE 50 ug/g; BETAMETHASONE DIPROPIONATE 64 mg/g · Cream · Topical · MC2 Therapeutics Ltd
NDC 73499-0001-01 · 1 TUBE in 1 CARTON / 60 g in 1 TUBE · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$1,368.85
Reported to Texas DSHS · 2026 annual filing · Mayne Pharma Commercial LLC
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for calcipotriene and betamethasone dipropionate (other) in the next 90 days
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- NDA213422
- TE code
- —
- Approval date
- Jul 20, 2020
- Patents / exclusivity
- 3 patents, 0 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| patent | 12440499 | Mar 18, 2039 |
| patent | 11696919 | Mar 18, 2039 |
| patent | 10265265 | Sep 27, 2027 |
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Calcipotriene and Betamethasone dipropionate (Cream)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| MC2 Therapeutics Ltd | CALCIPOTRIENE 50 ug/g; BETAMETHASONE DIPROPIONATE 64 mg/g | Aug 26, 2026 | Sep 2, 2026 |
| MC2 Therapeutics Ltd | CALCIPOTRIENE 64 mg/g; BETAMETHASONE DIPROPIONATE 50 ug/g | Jul 22, 2026 | Aug 19, 2026 |
| MC2 Therapeutics Ltd | BETAMETHASONE DIPROPIONATE 64 mg/g; CALCIPOTRIENE 50 ug/g | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Wynzora — NDC 73499-0001-01," retrieved September 3, 2026, https://drugdashboards.com/drug/73499000101.
Free to cite with attribution — see how the data is put together.